Veronica J. Alexander
机构：Ionis Pharmaceuticals (United States) · ORCID：0000-0003-3729-5749
发表论文 84 篇 · 总被引 4885 次 · h-index 27
代表论文
- Targeting APOC3 with Olezarsen in Moderate Hypertriglyceridemia (2025 · New England Journal of Medicine · 被引 69)
- Olezarsen for Managing Severe Hypertriglyceridemia and Pancreatitis Risk (2025 · New England Journal of Medicine · 被引 55)
- Olezarsen in patients with hypertriglyceridemia at high cardiovascular risk: Rationale and design of the Essence–TIMI 73b trial (2025 · American Heart Journal · 被引 15)
- Effect of APOC3 Inhibition With Olezarsen on Coronary Atherosclerosis: Essence-TIMI 73b Imaging Study (2026 · Circulation · 被引 10)
- Plasma reduction of apolipoprotein C-III with olezarsen leads to significant reductions in postprandial triglyceride levels: results from a randomized trial (2025 · European Journal of Preventive Cardiology · 被引 10)
- Effect of olezarsen on lipoprotein-associated ApoC-III levels in patients with familial chylomicronemia syndrome (2025 · Atherosclerosis · 被引 7)